APVMA Swimming Pool Sanitiser Registrations — After 20 Years of Questions, Is This The Scientific Evidence?

Two Freedom of Information Requests, Decades of Correspondence and a Fundamental Question That Remains Unanswered.

For more than 20 years, Enviroswim has questioned the Australian Pesticides and Veterinary Medicines Authority (APVMA) about the independent scientific evidence underpinning the registration of Australia’s three established categories of swimming pool and spa sanitisers: chlorine-based products, hydrogen peroxide and polyhexamethylene biguanide (PHMB).

After decades of correspondence, two Freedom of Information requests and our most recent statutory information request, the APVMA has provided the documents published below, including its formal response dated 23 October 2026.

What has been disclosed raises serious questions about the scientific foundations of Australia’s pool sanitiser regulatory system.

Several of the regulatory assessments rely on the registration of existing reference products, arguments of chemical similarity and assumptions of equivalent efficacy, rather than presenting independent microbiological test results demonstrating the performance of the products concerned.

Some supporting scientific reports are referenced, and one laboratory efficacy report has been provided with extensive redactions. However, the documents released do not establish a complete, independently verifiable chain of microbiological efficacy evidence back to the original reference-product registrations.

This leads to a fundamental question:

Where are the original independent laboratory studies demonstrating that these established sanitiser technologies satisfy clearly defined microbial kill requirements at their approved operating concentrations and exposure times?

Enviroswim is not suggesting that the absence of evidence from these released documents proves that no such evidence exists. We are questioning why, after more than two decades of requests, the underlying scientific justification for these longstanding regulatory approvals remains so difficult to independently examine.

For an industry responsible for protecting public health, we believe this level of scientific transparency is essential.

If the scientific evidence exists, it should be possible to identify it, explain its relevance and make its findings available for independent scrutiny.

We are publishing these official APVMA records in the public interest so that scientists, industry professionals, regulators and the Australian public can examine the material and draw their own conclusions.

All documents listed below are available for independent examination and download.

Read the APVMA responses 

The documents

Apvma Freedom of Information and Statutory Discolosure Documents — 2014 – 2026 

G11233 Freedom Of Information Request Notice Of Decision On Access Efficacy Of Chlorine and Hydrogen Peroxide

When asked to provide the scientific evidence supporting the registration of three specified swimming pool sanitisers against its own 2014 efficacy guidelines, the APVMA’s response was unequivocal: *“The documents sought do not exist.”* The APVMA explained that no applications or reviews had triggered assessment against those guidelines.

Read PDF ↗

2026-070-ACR Covering Letter

In October 2026, the APVMA supplied eight documents in response to Enviroswim’s request for scientific efficacy evidence. Four concerned hydrogen peroxide and PHMB sanitisers the APVMA itself cancelled in 2020 for failing its sanitiser performance criteria. Those cancellations were subsequently set aside on natural justice grounds, without disproving the regulator’s scientific concerns.

Read PDF ↗

83311 Perox Pro Chlorine Free Efficacy Report

A 21-page ALS Environmental scientific report dated November 2015, identifying laboratory testing, field trials, results and recommendations. However, almost all substantive technical findings have been withheld as confidential commercial information. Consequently, the publicly released document provides insufficient detail to independently examine the test conditions, microbial reduction results or demonstrated sanitising efficacy.

Read PDF ↗

87715 Summary Of Assessment (PHMB)

This APVMA assessment concerns a polyhexanide-based spa sanitiser. The regulator relies on formulation similarity to an existing registered product, Crystal Waters Spa Sanitiser, to support its conclusions concerning safety and efficacy. The released extract contains no independent microbial kill-test results, exposure times or quantified evidence demonstrating the proposed product’s sanitising performance.

Read PDF ↗

87715 Satisfaction Of Efficacy Criteria (PHMB)

This official APVMA delegate’s decision states that the product satisfies statutory efficacy requirements because it is closely similar to an existing registered reference product. Rather than presenting new laboratory efficacy results, the decision relies on the reference product’s previous registration. No organism-specific disinfection results or microbial reduction measurements are disclosed.

 Read PDF ↗

88288 Summary Of Assessment (Hydrogen Peroxide)

The APVMA assessment identifies Poppit Sanitiser as the registered reference product supporting this hydrogen peroxide sanitiser’s approval. The decision relies on similarities in formulation and an assessment that the proposed product presents no greater risk. The disclosed extract does not provide direct laboratory evidence of microbial kill rates or sanitising performance.

Read PDF ↗

88288 Satisfaction Of Efficacy Criteria (Hydrogen Peroxide)

This APVMA delegate’s decision confirms that statutory efficacy requirements were considered satisfied through close similarity to an already registered product. The reasoning relies on previous regulatory assessments rather than presenting new product-specific microbiological trials. No measured bacterial reductions, contact times or independently verifiable laboratory efficacy results appear in the released extract.

Read PDF ↗

93754 Blu52 4 Week Pool Sanitiser March 2023 Efficacy (Chlorine)

This March 2023 consultant’s report supports product efficacy primarily through comparisons with previously registered chlorine treatments and calculated chlorine quantities. It references earlier field trials involving four pools, but presents no new organism-specific microbial kill testing for Blu52+. The report also acknowledges the continuing need for chlorine monitoring and supplementary dosing.

Read PDF ↗

93754 APVMA Efficacy Assessment Extract (Chlorine)

This extract reveals the APVMA’s consideration of a scientific argument comparing the proposed Blu52+ product with existing registered chlorine-based products. The assessment compares weekly available-chlorine quantities and similarities in use. However, the disclosed material contains no new laboratory results establishing microbial inactivation rates, exposure times or measured sanitising performance.

Read PDF ↗

93754 Satisfaction Of Efficacy Criteria (Chlorine)

This APVMA decision records satisfaction of statutory efficacy requirements based on existing registered product precedents and comparable available-chlorine dosing. The assessment does not disclose new microbiological testing demonstrating the proposed product’s actual disinfection performance. It illustrates the regulator’s reliance on established registrations and comparative chemical characteristics when reaching its efficacy conclusion.

Read PDF ↗

Additional Supporting Documentation 

Tweed Laboratory Reports ES1 2001 & ES3 2004

Independent NATA-accredited Tweed Laboratory testing (2001–2004) demonstrated Enviroswim’s microbiological efficacy against Pseudomonas aeruginosa. The 2001 ES1 tests showed chlorine-only treatments failing the 4-log reduction benchmark within 30 seconds. The 2004 ES3 achieved 4.895-log reduction in 30 seconds and 5.996-log within two minutes, raising important questions about comparative sanitiser efficacy evidence.

Tweed Lab ES1 Report  ↗

Tweed Lab ES3 Report ↗

Enviroswim Achieved NSF In 2009

In 2009, Enviroswim successfully achieved NSF/ANSI 50 certification following independent testing in the United States. This internationally recognised certification assessed the ES3 system against applicable swimming pool equipment performance requirements, providing independent verification of its technology and demonstrating Enviroswim’s longstanding commitment to scientific testing, product performance and internationally recognised standards.

View NSF Certification  ↗

The Evidence Question: Enviroswim and the APVMA, 2001–2026

The primary record establishes a longstanding scientific and administrative dispute between Watertech/Enviroswim and the APVMA: historical pathogen-specific laboratory experiments; a compulsory 2004 recall concerning an earlier unit and questions about the pre-decision procedure; favourable selected public pool water samples during 2004; a narrowly scoped 2014 FOI decision; published adverse 2020 assessments of specified peroxide and PHMB products; a court set-aside on natural-justice grounds; limited 2026 records searches; and an October 2026 disclosure based in part on similarity and scientific argument. Each event has a distinct evidentiary meaning and must not be enlarged into a universal claim about chemical efficacy, legality or institutional motive.

View The Evidence Question

Enviroswim Seeks Ombudsman Review of APVMA

Enviroswim’s July 2026 complaint to the Commonwealth Ombudsman challenges the APVMA’s handling of scientific efficacy evidence supporting registered swimming pool sanitisers. Drawing on over 20 years of correspondence, laboratory testing and FOI requests, it seeks independent scrutiny of regulatory decisions, scientific accountability and consistent efficacy requirements for all sanitising technologies.

View Ombudsman Complaint Concerning APVMA

The APVMA's 2020 Cancellation Decisions

In July 2020, the Australian Pesticides and Veterinary Medicines Authority (APVMA) formally decided to cancel the registrations and associated label approvals of specified swimming pool and spa sanitisers containing hydrogen peroxide or polyhexanide hydrochloride (PHMB). Its published reasons concluded that the products did not meet the relevant sanitiser performance criteria, giving rise to concerns under the statutory safety and labelling criteria. The reasons specifically addressed slow or inadequate bacterial inactivation, including performance against Legionella pneumophila. [1]

The decisions were challenged in the Federal Court. The APVMA’s own 2020–21 Annual Report confirms that, in February 2021, it consented to orders setting aside both the original cancellations and its internal review decisions on natural justice grounds. [2] That is a procedural legal outcome—not a judicial finding that the affected sanitisers met the APVMA’s microbiological efficacy requirements, nor a determination that its published scientific concerns had been disproved.

The documents released to Enviroswim in October 2026 bring this distinction back into focus. Certain extracts explain efficacy decisions by reference to earlier product registrations or formulation similarity, while much of one underlying laboratory-and-field report is redacted. Those disclosures do not, on their face, resolve the question raised by the APVMA’s own 2020 findings.

The unanswered question: What independently verifiable, organism-specific efficacy evidence—including microbial log reductions, exposure times and operating concentrations—now reconciles the APVMA’s published 2020 findings with the subsequent or continuing registration of these sanitiser technologies? If that evidence exists, where can the public examine it?

A cancellation overturned on natural justice grounds is not the same thing as microbiological efficacy being demonstrated.

OFFICIAL PRIMARY SOURCES

[1] APVMA Gazette No. 15, 28 July 2020, pp. 29–35 (statement of reasons and affected products). Read the official Gazette (PDF)

[2] APVMA Annual Report 2020–21, p. 57, “Judicial decisions and reviews by outside bodies.” Read the official Annual Report (PDF)

Additional background: APVMA Gazette No. 6, 24 March 2020, p. 33, notice of review. Read the official notice (PDF)

Publication note: This section distinguishes the 2020 regulatory findings from the later legal result. It does not assert that every affected product remains registered in October 2026 or that no subsequent efficacy evidence exists; those matters require product-specific verification.